The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases
Open accessAbstract
A recent meeting was held on March 22, 2019, among the FDA, clinical scientists, pharmaceutical and biotech companies, clinical trials cooperative groups, and patient advocacy groups to discuss challenges and potential solutions for increasing development of therapeutics for central nervous system metastases. A key issue identified at this meeting was the need for consistent tumor measurement for reliable tumor response assessment, including the first step of standardized image acquisition with an MRI protocol that could be implemented in multicenter studies aimed at testing new therapeutics. This document builds upon previous consensus recommendations for a standardized brain tumor imaging protocol (BTIP) in high-grade gliomas and defines a protocol for brain metastases (BTIP-BM) that addresses unique challenges associated with assessment of CNS metastases. The “minimum standard” recommended pulse sequences include: (i) parameter matched pre- and post-contrast inversion recovery (IR)–prepared, isotropic 3D T1-weighted gradient echo (IR-GRE); (ii) axial 2D T2-weighted turbo spin echo acquired after injection of gadolinium-based contrast agent and before post-contrast 3D T1-weighted images; (iii) axial 2D or 3D T2-weighted fluid attenuated inversion recovery; (iv) axial 2D, 3-directional diffusion-weighted images; and (v) post-contrast 2D T1-weighted spin echo images for increased lesion conspicuity. Recommended sequence parameters are provided for both 1.5T and 3T MR systems. An “ideal” protocol is also provided, which replaces IR-GRE with 3D TSE T1-weighted imaging pre- and post-gadolinium, and is best performed at 3T, for which dynamic susceptibility contrast perfusion is included. Recommended perfusion parameters are given.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barnholtz-Sloan, J. S., Sloan, A. E., Davis, F. G., Vigneau, F. D., Lai, P., & Sawaya, R. E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.149 · Cited by 1,843
Brown, P. D., Jaeckle, K., Ballman, K. V., Farace, E., Cerhan, J. H., Anderson, S. K., Carrero, X. W., Barker, F. G., Deming, R., Burri, S. H., et al. (2016) · JAMA · doi:10.1001/jama.2016.9839 · Cited by 1,671
Self-citationSperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.0527 · Cited by 1,425
Self-citationEpidemiology of Brain Metastases
Nayak, L., Lee, E. Q., & Wen, P. Y. (2012) · Current Oncology Reports · doi:10.1007/s11912-011-0203-y · Cited by 1,361
Self-citationIntracranial gadolinium deposition after contrast-enhanced MR imaging
McDonald, R. J., McDonald, J. S., Kallmes, D. F., Jentoft, M. E., Murray, D. L., Thielen, K. R., Williamson, E. E., & Eckel, L. J. (2015) · Radiology · doi:10.1148/radiol.15150025 · Cited by 1,358
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Tawbi, H. A., Forsyth, P. A., Algazi, A., Hamid, O., Hodi, F. S., Moschos, S. J., Khushalani, N. I., Lewis, K., Lao, C. D., Postow, M. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805453 · Cited by 1,321
Brown, P. D., Ballman, K. V., Cerhan, J. H., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30441-2 · Cited by 1,220
Self-citationResponse assessment criteria for brain metastases: proposal from the RANO group
Lin, N. U., Lee, E. Q., Aoyama, H., Barani, I. J., Barboriak, D. P., Baumert, B. G., Bendszus, M., Brown, P. D., Camidge, D. R., Chang, S. M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70057-4 · Cited by 1,088
Self-citationLong, G. V., Atkinson, V., Lo, S., Sandhu, S., Guminski, A. D., Brown, M. P., Wilmott, J. S., Edwards, J., Gonzalez, M., Scolyer, R. A., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30139-6 · Cited by 987
Solomon, B. J., Besse, B., Bauer, T. M., Felip, E., Soo, R. A., Camidge, D. R., Chiari, R., Bearz, A., Lin, C.-C., Gadgeel, S. M., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30649-1 · Cited by 791
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Okada, H., Weller, M., Huang, R., Finocchiaro, G., Gilbert, M. R., Wick, W., Ellingson, B. M., Hashimoto, N., Pollack, I. F., Brandes, A. A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00088-1 · Cited by 781
Self-citationDistribution of Brain Metastases
Delattre, J. Y., Krol, G., Thaler, H. T., & Posner, J. B. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520310047016 · Cited by 778
Brain metastases: Histology, multiplicity, surgery, and survival
Nussbaum, E. S., Djalilian, H. R., Cho, K. H., & Hall, W. A. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19961015)78:8<1781::aid-cncr19>3.0.co;2-u · Cited by 679
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
(2015) · Neuro-Oncology · doi:10.1093/neuonc/nov095 · Cited by 663
Sperduto, P. W., Yang, T. J., Beal, K., Pan, H., Brown, P. D., Bangdiwala, A., Shanley, R., Yeh, N., Gaspar, L. E., Braunstein, S., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3834 · Cited by 659
Self-citationRecent trends in epidemiology of brain metastases: an overview.
Tabouret, É., Chinot, O. L., Métellus, P., Tallet, A. R., Viens, P., & Gonçalvès, A. (2012) · PubMed · Cited by 423
Cancer: Principles and Practice of Oncology
Levi, J. A. (1987) · Pathology · doi:10.1016/s0031-3025(16)39749-5 · Cited by 404
Optimized three‐dimensional fast‐spin‐echo MRI
Mugler, J. P. (2014) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24542 · Cited by 376
Sneed, P. K., Mendez, J., Vemer-van den Hoek, J. G. M., Seymour, Z. A., Ma, L., Molinaro, A. M., Fogh, S. E., Nakamura, J. L., & McDermott, M. W. (2015) · Journal of Neurosurgery · doi:10.3171/2014.10.jns141610 · Cited by 352
Freedman, R. A., Gelman, R. S., Anders, C. K., Melisko, M. E., Parsons, H. A., Cropp, A. M., Silvestri, K., Cotter, C. M., Componeschi, K. P., Marte, J. M., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01511 · Cited by 341
Self-citationMR diffusion imaging of human intracranial tumours
Krabbe, K., Gideon, P., Wagn, P., Hansen, U., Thomsen, C., & Madsen, F. (1997) · Neuroradiology · doi:10.1007/s002340050450 · Cited by 330
Gadgeel, S., Peters, S., Mok, T., Shaw, A. T., Kim, D. W., Ou, S. I., Pérol, M., Wrona, A., Novello, S., Rosell, R., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy405 · Cited by 318
Leptomeningeal metastases: a RANO proposal for response criteria
Chamberlain, M., Junck, L., Brandsma, D., Soffietti, R., Rudà, R., Raizer, J., Boogerd, W., Taillibert, S., Groves, M. D., Rhun, E. L., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now183 · Cited by 317
Self-citationDiagnostic Accuracy of MRI Compared to CCT in Patients with Brain Metastases
Schellinger, P. D., Meinck, H. M., & Thron, A. (1999) · Journal of Neuro-Oncology · doi:10.1023/a:1006308808769 · Cited by 299
Kohutek, Z. A., Yamada, Y., Chan, T. A., Brennan, C. W., Tabar, V., Gutin, P. H., Jonathan Yang, T., Rosenblum, M. K., Ballangrud, Å., Young, R. J., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1881-3 · Cited by 296
Hayashida, Y., Hirai, T., Morishita, S., Kitajima, M., Murakami, R., Korogi, Y., Makino, K., Nakamura, H., Ikushima, I., Yamura, M., et al. (2006) · PubMed Central · Cited by 296
Barajas, R., Chang, J. S., Sneed, P. K., Segal, M. R., McDermott, M. W., & Cha, S. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1362 · Cited by 278
Immunotherapy in melanoma: Recent advances and future directions
Franklin, C., Livingstone, E., Roesch, A., Schilling, B., & Schadendorf, D. (2017) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2016.07.145 · Cited by 278
Updates in the management of brain metastases
Arvold, N. D., Lee, E. Q., Mehta, M. P., Margolin, K., Alexander, B. M., Lin, N. U., Anders, C. K., Soffietti, R., Camidge, D. R., Vogelbaum, M. A., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now127 · Cited by 275
Self-citationDavis, F. G., Dolecek, T. A., McCarthy, B. J., & Villano, J. L. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos152 · Cited by 256
Intracranial hemorrhage caused by metastatic tumors
MANDYBUR, T. I. (1977) · Neurology · doi:10.1212/wnl.27.7.650 · Cited by 251
Sze, G. K., Milano, E., Johnson, C., & Heier, L. (1990) · PubMed Central · Cited by 240
A Review of MR Physics: 3T versus 1.5T
Soher, B. J., Dale, B. M., & Merkle, E. M. (2007) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2007.06.002 · Cited by 235
Brain metastases: neuroimaging
(2018) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-811161-1.00007-4 · Cited by 223
Mitsuya, K., Nakasu, Y., Horiguchi, S., Harada, H., Nishimura, T., Bando, E., Okawa, H., Furukawa, Y., Hirai, T., & Endo, M. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0106-z · Cited by 205
Epidemiology and prognosis of brain metastases
Stelzer, K. (2013) · Surgical Neurology International · doi:10.4103/2152-7806.111296 · Cited by 201
Galldiks, N., Stoffels, G., Filss, C. P., Piroth, M. D., Sabel, M., Ruge, M. I., Herzog, H., Shah, N. J., Fink, G. R., Coenen, H. H., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.103325 · Cited by 190
Seute, T., Leffers, P., ten Velde, G. P. M., & Twijnstra, A. (2008) · Cancer · doi:10.1002/cncr.23361 · Cited by 188
Yuh, W. T. C., Talı, E. T., Nguyen, H. D., et al. (1995) · PubMed · Cited by 173
Hoefnagels, F. W. A., Lagerwaard, F. J., Sanchez, E., Haasbeek, C. J. A., Knol, D. L., Slotman, B. J., & Peter Vandertop, W. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5034-5 · Cited by 168
Peng, L. C., Parekh, V. S., Huang, P., Lin, D. D. M., Sheikh, K., Baker, B. R., Kirschbaum, T., Silvestri, F., Son, J., Robinson, A., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.05.041 · Cited by 155
Fukuoka, H., Hirai, T., Okuda, T., Shigematsu, Y., Sasao, A., Kimura, E., Hirano, T., Yano, S., Murakami, R., & Yamashita, Y. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1937 · Cited by 152
Increased detection of intracranial metastases with intravenous Gd-DTPA.
Healy, M. E., Hesselink, J. R., Press, G. A., & Middleton, M. S. (1987) · Radiology · doi:10.1148/radiology.165.3.3317496 · Cited by 152
Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases.
Yuh, W. T. C., Engelken, J. D., Muhonen, M. G., Mayr, N. A., Fisher, D. J., & Ehrhardt, J. C. (1992) · PubMed Central · Cited by 148
Lin, N., Wefel, J. S., Lee, E. Q., Schiff, D., van den Bent, M. J., Soffietti, R., Suh, J. H., Vogelbaum, M. A., Mehta, M. P., Dancey, J. E., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70308-5 · Cited by 147
Self-citationLizárraga, K. J., Allen-Auerbach, M., Czernin, J. G., DeSalles, A. A. F., Yong, W. H., Phelps, M. E., & Chen, W. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.121418 · Cited by 140
Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis
Lohmann, P., Köcher, M., Ceccon, G. S., Bauer, E. K., Stoffels, G., Viswanathan, S., Ruge, M. I., Neumaier, B., Shah, N. J., Fink, G. R., et al. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.08.024 · Cited by 137
Rhun, É. L., Devos, P., Boulanger, T., Smits, M., Brandsma, D., Rudà, R., Furtner, J., Hempel, J.-M., Postma, T. J., Roth, P., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz024 · Cited by 136
Self-citationKato, Y., Higano, S., Tamura, H., Mugikura, S., Umetsu, A., Murata, T., & Takahashi, S. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1506 · Cited by 132
Lin, N., Lee, E. Q., Aoyama, H., Barani, I. J., Baumert, B. G., Brown, P. D., Camidge, D. R., Chang, S. M., Dancey, J. E., Gaspar, L. E., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70311-5 · Cited by 132
Self-citationCeccon, G. S., Lohmann, P., Stoffels, G., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now149 · Cited by 132
Willats, L., & Calamante, F. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2833 · Cited by 130
Kaewlai, R., & Abujudeh, H. H. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.8144 · Cited by 118
3T MRI: Advances in brain imaging
Álvarez‐Linera, J. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.02.045 · Cited by 116
Sahgal, A., Ruschin, M., Ma, L., Verbakel, W. F. A. R., Larson, D. A., & Brown, P. D. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox001 · Cited by 110
Self-citationMagnetic Resonance Imaging Contrast Enhancement of Brain Tumors at 3 Tesla Versus 1.5 Tesla
Nöebauer-Huhmann, I.-M., Ba‐Ssalamah, A., Mlynárik, V., et al. (2002) · Investigative Radiology · doi:10.1097/00004424-200203000-00003 · Cited by 108
Effect of Contrast Dose and Field Strength in the Magnetic Resonance Detection of Brain Metastases
Ba‐Ssalamah, A., Nöebauer-Huhmann, I.-M., Pinker, K., et al. (2003) · Investigative Radiology · doi:10.1097/01.rli.0000067488.57101.bd · Cited by 106
Nagao, E., Yoshiura, T., Hiwatashi, A., et al. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2343 · Cited by 104
Åkeson, P., Larsson, E.-M., Kristoffersen, D. T., Jonsson, E. L., & Holtås, S. (1995) · Acta Radiologica · doi:10.1177/028418519503600318 · Cited by 92
High‐dose gadoteridol in MR imaging of intracranial neoplasms
Runge, V. M., KIRSCH, J. E., Burke, V. J., Price, A. C., Nelson, K. L., Thomas, G. S., Dean, B. L., & Lee, C. (1992) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880020103 · Cited by 90
Detection of brain metastasis at 3T: comparison among SE, IR-FSE and 3D-GRE sequences
Kakeda, S., Korogi, Y., Hiai, Y., Ohnari, N., Moriya, J., Kamada, K., Hanamiya, M., Satô, T., & Kitajima, M. (2007) · European Radiology · doi:10.1007/s00330-007-0599-9 · Cited by 89
Danieli, L., Riccitelli, G. C., Distefano, D., Prodi, E., Ventura, E., Cianfoni, A., Kaelin‐Lang, A., Reinert, M., & Pravatà, E. (2019) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6096 · Cited by 89
Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases.
Yuh, W. T. C., Fisher, D. J., Runge, V. M., Atlas, S. W., Harms, S. E., Maravilla, K. R., Mayr, N. A., Mollman, J. E., & Price, A. C. (1994) · PubMed Central · Cited by 85
Kushnirsky, M., Nguyen, V., Katz, J. S., Steinklein, J. M., Rosen, L. M., Warshall, C., Schulder, M., & Knisely, J. P. S. (2015) · Journal of neurosurgery · doi:10.3171/2015.2.jns141993 · Cited by 81
Hematogenous metastases of the human brain – Characteristics of peritumoral brain changes: A review
Zhang, M., & Olsson, Y. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005799805335 · Cited by 79
Bauknecht, H.-C., Romano, V. C., Rogalla, P., Klingebiel, R., Wolf, C., Bornemann, L., Hamm, B., & Hein, P. A. (2009) · Investigative Radiology · doi:10.1097/rli.0b013e3181c02ed5 · Cited by 77
Suh, C. H., Jung, S. C., Kim, K. W., & Pyo, J. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2185-y · Cited by 73
Suzuki, K., Yamamoto, M., Hasegawa, Y., Ando, M., Shima, K., Sako, C., Ito, G., & Shimokata, K. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.05.011 · Cited by 71
DiLuna, M. L., King, J. T., Knisely, J. P. S., & Chiang, V. (2006) · Cancer · doi:10.1002/cncr.22367 · Cited by 68
Li, H., Deng, L., Bai, H. X., Sun, J., Cao, Y., Tao, Y., States, L. J., Farwell, M. D., Zhang, P. J., Xiao, B., et al. (2017) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5472 · Cited by 67
Symptomatic management and imaging of brain metastases
Kaal, E. C. A., TAPHOORN, M. J. B., & Vecht, C. J. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-8094-5 · Cited by 65
Eichler, A. F., & Plotkin, S. R. (2008) · Current Treatment Options in Neurology · doi:10.1007/s11940-008-0033-x · Cited by 61
Zach, L., Guez, D., Last, D., Daniels, D., Grober, Y., Nissim, O., Hoffmann, C., Nass, D., Talianski, A., Spiegelmann, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052008 · Cited by 56
Yamada, K., Kubota, H., Kizu, O., Nakamura, H., Ito, H., Yuen, S., Tanaka, O., Kubota, T., Makino, M., CAUTEREN, M. V., et al. (2002) · Stroke · doi:10.1161/01.str.0000020355.29423.61 · Cited by 56
Lai, G., Mahadevan, A., Hackney, D. B., et al. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4475 · Cited by 53
Anzalone, N., Gerevini, S., Scotti, R., Vezzulli, P. Q., & Picozzi, P. (2009) · Acta Radiologica · doi:10.1080/02841850903095385 · Cited by 52
Anzalone, N., Scarabino, T., Venturi, C., et al. (2011) · European Journal of Radiology · doi:10.1016/j.ejrad.2011.07.005 · Cited by 46
Radiotherapy and chemotherapy of brain metastases
Soffietti, R., Costanza, A., Laguzzi, E., Nobile, M., & Rudà, R. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-8096-3 · Cited by 43
Knitter, J. R., Erly, W. K., Stea, B., Lemole, G. M., Germano, I. M., Doshi, A. H., & Nael, K. (2018) · American Journal of Roentgenology · doi:10.2214/ajr.17.18890 · Cited by 41
Semmineh, N. B., Bell, L. C., Stokes, A. M., Hu, L., Boxerman, J. L., & Quarles, C. C. (2018) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5827 · Cited by 38
Self-citationHigh‐dose applications of gadolinium chelates in magnetic resonance imaging
Runge, V. M., Kirsch, J. E., & Thomas, G. S. (1991) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910220241 · Cited by 35
Review of Imaging Techniques in the Diagnosis and Management of Brain Metastases
Lignelli, A., & Khandji, A. G. (2010) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2010.09.002 · Cited by 33
Taunk, N. K., Oh, J. H., Shukla‐Dave, A., Beal, K. P., Vachha, B. A., Holodny, A. I., & Hatzoglou, V. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox159 · Cited by 32
Cohen‐Inbar, O., Xu, Z., Dodson, B. K., Rizvi, T., Durst, C. R., Mukherjee, S., & Sheehan, J. P. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2242-6 · Cited by 29
Comparison of Brain Tumor Contrast-enhancement on T1-CUBE and 3D-SPGR Images
Majigsuren, M., Takashi, A. B. E., Kageji, T., Matsuzaki, K., Takeuchi, M., Iwamoto, S., Otomi, Y., Uyama, N., Nagahiro, S., & Harada, M. (2015) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.2014-0129 · Cited by 28
Vaněčková, M., Heřman, M., Smith, M. P., Mechl, M., Maravilla, K. R., Weichet, J., Spampinato, M. V., Žižka, J., Wippold, F. J., Baima, J. J., et al. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4468 · Cited by 28
Self-citationJeon, J. Y., Choi, J. W., Roh, H. G., et al. (2014) · Korean Journal of Radiology · doi:10.3348/kjr.2014.15.1.145 · Cited by 28
The Holy Grail in diagnostic neuroradiology: 3T or 3D?
Barkhof, F., Pouwels, P. J. W., & Wattjes, M. P. (2010) · European Radiology · doi:10.1007/s00330-010-2034-x · Cited by 27
Significance of histology in determining management of lesions regrowing after radiosurgery
Nath, S. K., Sheridan, A. D., Rauch, P. J., Yu, J. B., Minja, F. J., Vortmeyer, A. O., & Chiang, V. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1389-2 · Cited by 22
Yoon, B. C., Saad, A. F., Rezaii, P. G., Wintermark, M., Zaharchuk, G., & Iv, M. (2018) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5747 · Cited by 16
Suh, C. H., Kim, H. S., Jung, S. C., Choi, C. G., & Kim, S. J. (2018) · American Journal of Roentgenology · doi:10.2214/ajr.18.19674 · Cited by 16
Leiva‐Salinas, C., Muttikkal, T. J. E., Flors, L., Puig, J., Wintermark, M., Patrie, J. T., Rehm, P. K., Sheehan, J. P., & Schiff, D. (2018) · American Journal of Roentgenology · doi:10.2214/ajr.18.20006 · Cited by 15
Shah, K. B., Guha‐Thakurta, N., Schellingerhout, D., Madewell, J. E., Kumar, A. J., & Costelloe, C. M. (2011) · American Journal of Roentgenology · doi:10.2214/ajr.10.4887 · Cited by 8
Cited by
Le Rhun, E., Guckenberger, M., Smits, M., Dummer, R., Bachelot, T., Sahm, F., Galldiks, N., de Azambuja, E., Berghoff, A. S., Metellus, P., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.07.016 · Cited by 592
Self-citationEpidemiology of brain metastases and leptomeningeal disease
Lamba, N., Wen, P. Y., & Aizer, A. A. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab101 · Cited by 406
Self-citationCho, J., Kim, Y. J., Sunwoo, L., Lee, G. P., Nguyen, T. Q., Cho, S. J., Baik, S. H., Bae, Y. J., Choi, B. S., Jung, C., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.739639 · Cited by 30
“The introduction of three-dimensional (3D) sequences in MRI, which allows the acquisition of thin-section thickness images in a reasonable time, has signi fi cantly enhanced the sensitivity of BM detection, particularly for small nodules (5, 6).”
Background
Metadata
- Authors
- Kaufmann, T. J., Smits, M., Boxerman, J., Huang, R., Barboriak, D. P., Weller, M., Chung, C., Tsien, C., Brown, P. D., Shankar, L., Galanis, E., Gerstner, E., van den Bent, M. J., Burns, T. C., Parney, I. F., Dunn, G., Brastianos, P. K., Lin, N. U., Wen, P. Y., & Ellingson, B. M.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-02-12
- Volume
- 22
- Issue
- 6
- Pages
- 757-772
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W3005961708
- Cited by
- 267
- References
- 93
- FWCI
- 15.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.